To view this, you need to install the Flash Player 5. Please go to here and download it.

Personal Injury Blog

Fungal Meningitis Lawsuit Filed

September 24, 2014 @ 04:31 PM — by Jim Pettit
Tagged with:
Locks Law Firm LLC has filed suit for a patient who received a fungal-contaminated steroid injection in his spine, causing fungal meningitis. The steroid product came from New England Compounding Center ("NECC") in Massachusetts. Federal officials shut down NECC in 2012 because NECC was producing lots of methylprednisolone acetate (MPA) which were contaminated. The Center for Disease Control (CDC) states the contaminated steroids caused 64 deaths and hundreds of patients were caused to have meningitis. Approximately 45 cases have been filed in New Jersey and many more have been filed around the country. There are about 300 cases in the federal Multidistrict Litigation (MDL). 

Johnson & Johnson withdrawing surgical tool that can spread cancer in women

August 01, 2014 @ 10:08 AM — by Admin

On Wednesday, July 30th, Johnson & Johnson announced it was withdrawing a surgical tool that can spread cancer in women.  This voluntary recall removed the devices made by the largest manufacturer of those devices from the market amid a contentious debate over its use.

The company planned to tell customers world-wide in a letter to return the devices known as laparoscopic power morcellators. J&J already suspended sales of new morcellators in April after the U.S. Food and Drug Administration advised doctors not to use the tool, which slices up common uterine masses called fibroids, and uteruses themselves, into fragments so they can be removed in minimally invasive surgery. In April, J&J defended the safety of the tool but said it was waiting for more guidance from the medical community.

FDA to Require Blood Clot Warnings on Testosterone Products

June 23, 2014 @ 09:19 AM — by Admin

On June 20, 2014 the United States Food and Drug Administration announced that it would require the manufacturers of all approved testosterone products to include a warning in the drug labeling about the risk of blood clots in the veins, also known as venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). See the FDA announcement here (http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm402054.htm)....

...The Locks Law Firm is actively investigating cases of stroke, heart attack, blood clots in the veins, pulmonary embolism and death in users of testosterone products, especially those prescribed for what is known as "low-T syndrome." If you, a friend or a loved one has used a testosterone gel, cream, patch or other testosterone formulation and suffered any of the conditions mentioned above, please contact the Locks Law Firm.

Jerry Lindheim on the Afternoon Drive show on WPHT 1210AM regarding Nursing Home Abuse

April 10, 2014 @ 04:29 PM — by Admin
Tagged with:

On the 21st day of March,  Jerry Lindheim, Esquire-partner at the Locks Law Firm was featured on the Dick Morris Afternoon Drive radio broadcast WPHT 1210AM during which time he discussed nursing home neglect and abuse and patient's rights and remedies.  

http://www.podtrac.com/pts/redirect.mp3/nyc.podcast.play.it/media/d0/d0/d1/d4/dV/dU/dQ/14VUQ_3.MP3

Risperdal Cases

February 28, 2014 @ 12:11 PM — by Leon Carpenter
Tagged with: Risperdal

Locks Law Firm announces it is now accepting Risperdal cases.

Zimmer Durom Cup Hip Replacement Cases

February 28, 2014 @ 12:04 PM — by Leon Carpenter

Locks Law Firm announces it is now accepting Zimmer Durom cup hip replacement cases.

Locks Law Firm announces it is handling claims against the manufacturers and distributors of testosterone-based products

February 09, 2014 @ 08:27 PM — by Leon Carpenter

Last week the U.S. Food and Drug Administration said it has begun investigating the risk of stroke, heart attack and death in men taking prescription testosterone drugs.

The announcement came on the heels of two recent two studies that suggested an increased risk of heart attacks in men who take testosterone, a hormone produced in the testicles that is responsible for maintaining muscle bulk, bone growth and sexual function, the FDA said. The FDA said it has not concluded that testosterone increases the risk of cardiac events but said it is issuing an alert "while we continue to evaluate the information from these studies and other available data."

Actos trial involves claim that Takeda destroyed files

January 30, 2014 @ 09:47 AM — by Admin

The first Actos trial in the federal MDL (Multi-District Litigation) system began this week in Louisiana. Federal Judge Rebecca Doherty ruled that the leadership demonstrated by Takeda (the maker of Actos) regarding files that were lost, deleted or destroyed was disturbing. The judge therefore ruled that plaintiffs' lawyers could tell jurors about the document destruction. Takeda is the largest drug company in Asia. Actos is a diabetes drug that causes bladder cancer. Sales of Actos peaked in March 2011 at $4.5 billion and accounted for 27% of Takeda's revenue at that point. Since Actos was released in 1999 it has generated over $16 billion in sales. If you or a loved one used Actos and developed bladder cancer contact Locks Law Firm on our TOLL FREE line to discuss if we can help you. 866-LOCKSLAW  (866-562-5752) 

Actos Trial Begins

January 28, 2014 @ 03:32 PM — by Admin

A jury was selected yesterday in the Allen trial, in the federal MDL (Multi-District Litigation)  in Louisiana, consisting of 7 women and 2 men. Opening arguments are scheduled for Monday, February 3rd. This will be the fourth trial. Two were wins for plaintiffs but the judge in each case overturned the verdict for plaintiffs. The third was a defense verdict. Actos is a diabetes drug that causes bladder cancer. If you or a loved onE took Actos and have been diagnosed with bladder cancer, please call our TOLL FREE number - 866-LOCKSLAW (866-562-5752).

Byetta/Januvia Lawsuits Centralized in MDL 2452

October 28, 2013 @ 02:29 PM — by Admin
Tagged with: Fda Byetta Januvia Victoza

Byetta is a popular injectable-type drug, sold by Bristol-Myers Squibb (after it bought Amlyn Pharmacueticals which had been making it) for patients with Type-2 diabetes. Januvia is another one, sold by Merck. Other related drugs are Victoza (liraglutide) and also a form of Januvia called Janumet (sitagliptin combined with metaformin sold by Merck.  Victoza is sold by Novo Nordisk. The drugs are sometimes called incretin mimetics. These drugs seem to work by mimicking the incretin hormone GLP-1 that the body usually produces naturally to stimulate the release of insulin in response to eating a meal, and/or by inhibiting the effect the enzyme DPP-4. (cont.)

Share |

Back to top